Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate the business. The company had been planned to secure permission from ...

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

On his visit to the islands in 1835, Charles Darwin noticed the slight differences between the same types of animal on each island. This helped him work out how they had adapted to their ...